ASXC
Income statement / Annual
Last year (2023), Asensus Surgical, Inc.'s total revenue was $8.58 M,
an increase of 21.02% from the previous year.
In 2023, Asensus Surgical, Inc.'s net income was -$78.43 M.
See Asensus Surgical, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$8.58 M
|
$7.09 M
|
$8.23 M
|
$3.18 M
|
$8.53 M
|
$24.10 M
|
$7.11 M
|
$1.52 M
|
$0.00
|
$401,000.00
|
| Cost of Revenue |
$13.61 M |
$10.87 M |
$11.10 M |
$5.17 M |
$20.73 M |
$16.17 M |
$6.73 M |
$1.07 M |
$2.19 M |
$1.10 M |
| Gross Profit |
-$5.03 M |
-$3.79 M |
-$2.86 M |
-$1.99 M |
-$12.20 M |
$7.93 M |
$384,000.00 |
$450,000.00 |
-$2.19 M |
-$694,000.00 |
| Gross Profit Ratio |
-0.59 |
-0.53 |
-0.35 |
-0.63 |
-1.43 |
0.33 |
0.05 |
0.3 |
0 |
-1.73 |
| Research and Development
Expenses |
$37.02 M
|
$28.94 M
|
$19.35 M
|
$16.62 M
|
$22.47 M
|
$21.82 M
|
$21.99 M
|
$29.27 M
|
$29.67 M
|
$27.94 M
|
| General & Administrative
Expenses |
$19.16 M
|
$20.17 M
|
$19.32 M
|
$14.14 M
|
$18.76 M
|
$13.85 M
|
$12.28 M
|
$10.81 M
|
$7.83 M
|
$6.24 M
|
| Selling & Marketing
Expenses |
$16.92 M
|
$14.76 M
|
$13.40 M
|
$13.06 M
|
$28.01 M
|
$25.74 M
|
$17.54 M
|
$9.15 M
|
$2.86 M
|
$1.73 M
|
| Selling, General &
Administrative Expenses |
$36.08 M
|
$34.93 M
|
$32.72 M
|
$27.20 M
|
$46.77 M
|
$39.59 M
|
$29.81 M
|
$19.96 M
|
$10.69 M
|
$7.97 M
|
| Other Expenses |
-$1.44 M |
$7.71 M |
$11.25 M |
$10.80 M |
$10.30 M |
$1.13 M |
-$300,000.00 |
$35,000.00 |
$2.19 M |
$0.00 |
| Operating Expenses |
$73.10 M |
$71.58 M |
$63.32 M |
$54.62 M |
$79.54 M |
$72.28 M |
$59.66 M |
$56.20 M |
$42.54 M |
$35.92 M |
| Cost And Expenses |
$86.71 M |
$82.45 M |
$74.42 M |
$59.79 M |
$100.27 M |
$88.45 M |
$66.39 M |
$57.27 M |
$42.54 M |
$37.01 M |
| Interest Income |
$1.55 M |
$1.14 M |
$590,000.00 |
$35,000.00 |
$582,000.00 |
$1.40 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$410,000.00 |
$370,000.00 |
$19,000.00 |
$4.61 M |
$4.21 M |
-$2.76 M |
-$1.89 M |
-$1.60 M |
-$1.04 M |
| Depreciation &
Amortization |
$3.73 M
|
$11.08 M
|
$14.11 M
|
$13.70 M
|
$12.47 M
|
$13.29 M
|
$10.34 M
|
$8.91 M
|
$3.43 M
|
$1.31 M
|
| EBITDA |
-$74.40 M
|
-$63.44 M
|
-$50.19 M
|
-$43.00 M
|
-$79.66 M
|
-$48.54 M
|
$36.83 M
|
$21.05 M
|
-$35.28 M
|
-$35.30 M
|
| EBITDA Ratio |
-8.67 |
-8.95 |
-6.1 |
-13.54 |
-9.34 |
-2.01 |
5.18 |
13.86 |
0 |
-88.03 |
| Operating Income Ratio
|
-9.11
|
-10.68
|
-7.85
|
-19.02
|
-18.12
|
-2.04
|
-8.71
|
-81.4
|
0
|
-91.29
|
| Total Other
Income/Expenses Net |
$11,000.00
|
$436,000.00
|
$2.38 M
|
-$439,000.00
|
-$2.75 M
|
$2.00 M
|
-$86.06 M
|
-$67.86 M
|
-$3.83 M
|
-$1.04 M
|
| Income Before Tax |
-$78.12 M |
-$75.24 M |
-$62.24 M |
-$60.83 M |
-$157.33 M |
-$65.15 M |
-$148.10 M |
-$125.50 M |
-$47.97 M |
-$37.65 M |
| Income Before Tax Ratio
|
-9.11
|
-10.62
|
-7.56
|
-19.16
|
-18.44
|
-2.7
|
-20.83
|
-82.62
|
0
|
-93.9
|
| Income Tax Expense |
$314,000.00 |
$318,000.00 |
$225,000.00 |
-$1.52 M |
-$3.12 M |
-$3.38 M |
-$3.30 M |
-$5.52 M |
-$1.02 M |
$0.00 |
| Net Income |
-$78.43 M |
-$75.56 M |
-$62.46 M |
-$59.31 M |
-$154.20 M |
-$61.78 M |
-$144.80 M |
-$119.98 M |
-$46.95 M |
-$37.65 M |
| Net Income Ratio |
-9.14 |
-10.66 |
-7.59 |
-18.68 |
-18.08 |
-2.56 |
-20.36 |
-78.99 |
0 |
-93.9 |
| EPS |
-0.31 |
-0.32 |
-0.28 |
-0.84 |
-8.69 |
-3.88 |
-0.97 |
-1.07 |
-0.59 |
-0.64 |
| EPS Diluted |
-0.31 |
-0.32 |
-0.28 |
-0.84 |
-8.69 |
-3.88 |
-0.97 |
-1.07 |
-0.59 |
-0.64 |
| Weighted Average Shares
Out |
$249.69 M
|
$236.49 M
|
$226.96 M
|
$70.81 M
|
$17.74 M
|
$15.94 M
|
$148.74 M
|
$112.19 M
|
$79.63 M
|
$58.71 M
|
| Weighted Average Shares
Out Diluted |
$249.69 M
|
$236.49 M
|
$226.96 M
|
$70.81 M
|
$17.74 M
|
$15.94 M
|
$148.74 M
|
$112.19 M
|
$79.63 M
|
$58.71 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
